Martin S J
Division of Molecular Biology, School of Biology and Biochemistry, The Queen's University of Belfast, Northern Ireland.
Biotechnol Adv. 1994;12(4):619-24. doi: 10.1016/0734-9750(94)90002-7.
Recent developments in the understanding of the structure and replications of a wide range of pathogens, including viruses, bacteria and parasites have opened up ways of designing novel vaccines which should both improve the quality and extend the range and value of vaccines as major prophylactic and therapeutic tools of the future. Two main strategies have emerged, one involving the development of synthetic vaccines which are essentially composed of selected epitopes of the pathogenic agent that will elicit neutralising antibodies. The other strategy attempts to make use of chimeric agents that will allow live virus or bacteria to be used as vectors for carrying appropriate epitopes of the target pathogen. Current knowledge about the immunology and improvements in the presentation of antigen to the immune system will also play an important role in the rational design of vaccines. This review summarises present methods of producing vaccines and considers the development of more rational methods of vaccine design that will greatly influence the production of vaccines in the future.
对包括病毒、细菌和寄生虫在内的多种病原体的结构和复制的最新认识进展,为设计新型疫苗开辟了道路,这些新型疫苗有望提高疫苗质量,并扩大其作为未来主要预防和治疗工具的范围及价值。出现了两种主要策略,一种是开发合成疫苗,其本质上由病原体的选定表位组成,这些表位可引发中和抗体。另一种策略试图利用嵌合制剂,使活病毒或细菌用作载体来携带靶病原体的适当表位。目前关于免疫学的知识以及抗原呈递给免疫系统方式的改进,也将在疫苗的合理设计中发挥重要作用。本综述总结了目前生产疫苗的方法,并探讨了更合理的疫苗设计方法的发展,这将极大地影响未来疫苗的生产。